e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Different patterns of diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia
A. Kaga, Y. Yusui, F. Sakai, R. Sadakata, K. Kobayashi, M. Nagata, K. Hagiwara, M. Kanazawa (Saitama, Japan)
Source:
Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Session:
Different patterns of diffuse parenchymal lung disease
Session type:
Thematic Poster Session
Number:
810
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Kaga, Y. Yusui, F. Sakai, R. Sadakata, K. Kobayashi, M. Nagata, K. Hagiwara, M. Kanazawa (Saitama, Japan). Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia. Eur Respir J 2010; 36: Suppl. 54, 810
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
Clinical features of COPD in patients with chronic pulmonary aspergillosis
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 18: 43S-55S
Year: 2001
Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
Clinical significance of histological classification of idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 19: 275-283
Year: 2002
Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
Source: Eur Respir Rev 2012 21: 355-361
Year: 2012
Clinical course and morphological signs of idiopathic pulmonary fibrosis and interstitial pneumonias
Source: Eur Respir J 2004; 24: Suppl. 48, 536s
Year: 2004
Chronic pulmonary aspergillosis complicating sarcoidosis
Source: Eur Respir J, 49 (6) 1602396; 10.1183/13993003.02396-2016
Year: 2017
Chronic pulmonary aspergillosis in patients with post-tuberculosis bronchiectasis
Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Year: 2018
Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Clinicopathological features of the pulmonary aspergillosis with chronic interstitial pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia
Source: Eur Respir J 2002; 19: 1114-1118
Year: 2002
The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008
Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
PET‘s importance in chronic pulmonary aspergillosis
Source: Eur Respir J 2006; 28: Suppl. 50, 560s
Year: 2006
Clinical characteristics and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Allergic/invasive pulmonary aspergillosis in CGD (chronic granulomatous disease) patients
Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection
Year: 2009
Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009
Cyclosporine A in the treatment of idiopathic pulmonary fibrosis/usual interstitial pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 62s
Year: 2002
Clinical features of usual interstitial pneumonia-correlation between idiopathic pulmonary fibrosis and connective tissue disease associated with usual interstitial pneumonia
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept